About
The LOCI trial is a double-blinded placebo-controlled study.
Short title:Letrozole Or Clomifene for ovulation Induction
Full title: Letrozole or Clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome: a 2x2 factorial design randomised trial
Trial aim: To investigate the clinical and cost-effectiveness of letrozole or clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome.
NIHR HTA Funder Ref: 17/116/01
Sponsor Ref: RG_18-232
ISRCTN No.: 11828358
REC Ref: 19/WM/0364
IRAS No.: 257918
EudraCT No.: 2018-004641-16
Sponsor: University of Birmingham
Chief Investigator: Prof Arri Coomarasamy
Coordinating Centre: Birmingham Clinical Trials Unit, University of Birmingham
Short title:Letrozole Or Clomifene for ovulation Induction
Full title: Letrozole or Clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome: a 2x2 factorial design randomised trial
Trial aim: To investigate the clinical and cost-effectiveness of letrozole or clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome.
NIHR HTA Funder Ref: 17/116/01
Sponsor Ref: RG_18-232
ISRCTN No.: 11828358
REC Ref: 19/WM/0364
IRAS No.: 257918
EudraCT No.: 2018-004641-16
Sponsor: University of Birmingham
Chief Investigator: Prof Arri Coomarasamy
Coordinating Centre: Birmingham Clinical Trials Unit, University of Birmingham